Main > ONCOLOGY (**) > Colon Cancer>MET *** > Treatment > USA. T. VEGFR-1,2,3 Oral Inhibitor>

---

USA. T. VEGFR-1,2,3 Oral Inhibitor>'s subsections
(*) CN Approval Date: 2018. 09
(*) CN>HK Approval: 2024. 01.30
(*) USA Approval Date: 2023. 11.08
>Capsules
Company
Company CN; HK
Generic Name
Patent>CN Patent Numbers
Patent>USA Patent Numbers
TM CN HK
TM CN HK PR Web-Site
TM USA
TM USA Web-Site

USA. T. VEGFR-1,2,3 Oral Inhibitor>'s products
This section has no products